Literature DB >> 28602113

Primary Arthrodesis versus Open Reduction and Internal Fixation for Low-Energy Lisfranc Injuries in a Young Athletic Population.

Grant Cochran1, Christopher Renninger1, Trevor Tompane1, Joseph Bellamy2, Kevin Kuhn1.   

Abstract

BACKGROUND: There are 2 Level I studies comparing open reduction and internal fixation (ORIF) and primary arthrodesis (PA) in high-energy Lisfranc injuries. There are no studies comparing ORIF and PA in young athletic patients with low-energy injuries.
METHODS: All operatively managed low-energy Lisfranc injuries sustained by active duty military personnel at a single institution were identified from 2010 to 2015. The injury pattern, method of treatment, and complications were reviewed. Implant removal rates, fitness test scores, return to military duty rates, and Foot and Ankle Ability Measure (FAAM) scores were compared. Thirty-two patients were identified with the average age of 28 years. PA was performed in 14 patients with ORIF in 18.
RESULTS: The PA group returned to full duty at an average of 4.5 months whereas the ORIF group returned at an average of 6.7 months ( P = .0066). The PA group ran their fitness test an average of 9 seconds per mile slower than their preoperative average whereas the ORIF group ran it an average of 39 seconds slower per mile ( P = .032). There were no differences between the 2 groups in the FAAM scores at an average of 35 months. Implant removal was performed in 15 (83%) in the ORIF group and 2 (14%) in the PA group ( P = .005).
CONCLUSIONS: Low-energy Lisfranc injuries treated with primary arthrodesis had a lower implant removal rate, an earlier return to full military activity, and better fitness test scores after 1 year, but there was no difference in FAAM scores after 3 years. LEVEL OF EVIDENCE: Level III, comparative cohort study.

Entities:  

Keywords:  Lisfranc; ORIF; arthrodesis; midfoot

Mesh:

Year:  2017        PMID: 28602113     DOI: 10.1177/1071100717711483

Source DB:  PubMed          Journal:  Foot Ankle Int        ISSN: 1071-1007            Impact factor:   2.827


  8 in total

1.  Nonoperative, open reduction and internal fixation or primary arthrodesis in the treatment of Lisfranc injuries: a prospective, randomized, multicenter trial - study protocol.

Authors:  Ville T Ponkilainen; Ville M Mattila; Heikki-Jussi Laine; Antti Paakkala; Heikki M Mäenpää; Heidi H Haapasalo
Journal:  BMC Musculoskelet Disord       Date:  2018-08-21       Impact factor: 2.362

2.  Comparison of primary arthrodesis versus open reduction with internal fixation for Lisfranc injuries: Systematic review and meta-analysis.

Authors:  P F Han; Z L Zhang; C L Chen; Y C Han; X C Wei; P C Li
Journal:  J Postgrad Med       Date:  2019 Apr-Jun       Impact factor: 1.476

Review 3.  Lisfranc fracture-dislocations: current management.

Authors:  Inmaculada Moracia-Ochagavía; E Carlos Rodríguez-Merchán
Journal:  EFORT Open Rev       Date:  2019-07-02

Review 4.  Return to Play After Low-Energy Lisfranc Injuries in High-Demand Individuals: A Systematic Review and Meta-Analysis of Athletes and Active Military Personnel.

Authors:  Ahmed Khalil Attia; Karim Mahmoud; Abduljabbar Alhammoud; Pieter d'Hooghe; Daniel Farber
Journal:  Orthop J Sports Med       Date:  2021-03-08

5.  Updates on Lisfranc Complex Injuries.

Authors:  Alan Yan; Stephen R Chen; Xin Ma; Zhongmin Shi; MaCalus Hogan
Journal:  Foot Ankle Orthop       Date:  2021-01-25

6.  Staged surgery for closed Lisfranc injury with dislocation.

Authors:  Wenbao He; Jiang Xia; Haichao Zhou; Zhendong Li; Youguang Zhao; Yunfeng Yang; Bing Li
Journal:  Front Surg       Date:  2022-08-19

7.  A Systematic Review of Outcomes Following Lisfranc Injury Fixation: Removal vs Retention of Metalwork.

Authors:  Amanda M L Rhodes; Louise McMenemy; Richard Connell; Robin Elliot; Daniel Marsland
Journal:  Foot Ankle Orthop       Date:  2022-10-10

8.  Lisfranc fleck sign: characteristics and clinical outcomes following fixation using a percutaneous position Lisfranc screw.

Authors:  Moein Pourmorteza; Amir Reza Vosoughi
Journal:  Eur J Trauma Emerg Surg       Date:  2020-06-19       Impact factor: 3.693

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.